Abstract
Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I
Original language | English |
---|---|
Publication status | Accepted/In press - 12 Mar 2021 |
Event | ATS International Conference Committee: ATS 2021 - Virtual event Duration: 14 May 2021 → 19 May 2021 https://conference.thoracic.org/ |
Conference
Conference | ATS International Conference Committee |
---|---|
Period | 14/05/21 → 19/05/21 |
Internet address |